31 - Antibiotics & Anti-Fungals Flashcards

1
Q

What proportion of bacteria are pathogenic?

A

Around 1/3 of bacteria are pathogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What phylogenetic domain do bacteria occupy?

A

They have their own phylogenetic domain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Outline the structure of bacteria

A

Single-cell microorganisms

Cell wall

Cell membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is an important structural feature of gram positive bacteria and give an example?

A

Prominent peptidoglycan cell wall

e.g. staphylococcus aureus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is an important structural feature of gram negative bacteria and give an example?

A

Outer membrane with lipopolysaccharide

Less prominent cell wall than gram positive

Don’t stain with gram stain

e.g. escherichia coli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is an important structural feature of mycolic bacteria and give an example?

A

outer mycolic acid layer

(closer to gram positive than gram negative)

e.g. mycobacterium tuberculosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Outline the stages of prokaryotic protein synthesis

A

1. Nucleic Acid Synthesis

Dihydropteroate (DHOp)

  • Produced from paraaminobenzoate (PABA)
  • Converted into dihydrofolate (DHF)
  • DHOp enzyme

Tetrahydrofolate (THF)

  • Produced from DHF by DHF reductase
  • THF is important in DNA synthesis
  • DHF reductase enzyme

2. DNA Replication

DNA gyrase (Topoisomerase)

Topoisomerase leads to released tension

Allows enzymes to get access to nucleic acids/enzymes

3. RNA Synthesis

RNA polymerase

  • Produces RNA from DNA template
  • Differ from eukaryotic RNA polymerase

4. Protein Synthesis

Ribosomes

  • Produce protein from RNA templates
  • Differ from eukaryotic ribosomes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Outline the different protein synthesis inhibitors that are used against bacteria as antibiotics

A

1. Nucleic Acid Synthesis

Dihydropteroate (DHOp)

  • Sulphonamides inhibit DHOp synthase
  • DNA can’t be made and so the bacteria dies

Tetrahydrofolate (THF)

  • Trimethoprim inhibits DHF reductase

2. DNA Replication

DNA gyrase

  • Fluoroquinolones (e.g. Ciprofloxacin) inhibit DNA gyrase & topoisomerase IV
  • Prevent bacterial DNA from unwinding so bacteria can’t replicate

3. RNA Synthesis

RNA polymerase

  • The rifamycins (e.g. Rifampicin) inhibits bacterial RNA polymerase

4. Protein Synthesis

Ribosomes

Most targeted area by intracellular antibiotics

Inhibited by:

  • Aminoglycosides (e.g. Gentamicin)
  • Chloramphenicol
  • Macrolides (e.g. Erythromycin)
  • Tetracyclines

THESE STAGES ARE THE 4 MAJOR INTRACELLILAR TARGETS OF ANTIBIOTICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Outline the stages of bacterial wall synthesis

A

1. Peptidoglycan (PtG) Synthesis

A pentapeptide is created on N-acetyl muramicacid (NAM)

N-acetyl glucosamine (NAG) associates with NAM forming PtG

2. PtG Transportation

PtG is transported into periplasma across the membrane by a protein called bactoprenol

3. PtG Incorporation

PtG is incorporated into the cell wall when transpeptidase enzyme cross-links PtG pentapeptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Outline the different antibiotics that target stages of bacterial wall synthesis (bacterial wall inhibitors)

A

1. PtG Synthesis

Glycopeptides (e.g. Vancomycin) bind to the pentapeptide preventing PtG synthesis

2. PtG Transportation

Bacitracin inhibits bactoprenol regeneration preventing PtG transportation

3. PtG Incorporation

β-lactams bind covalently to transpeptidase inhibiting PtG incorporation into cell wall

β-lactams include:

  • Carbapenems
  • Cephalosporins
  • Penicillins

4. Cell Wall Stability

Becoming more important due to antibiotic resistance becoming more prevalent

Lipopeptide

  • e.g. daptomycin
  • disrupt Gram +ve cell walls

Polymyxins

  • binds to LPS (lipopolysaccharides)
  • disrupts Gram -ve cell membranes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the timeline of antibiotic resistance

A

Antibiotics with new mechanisms are not being produced regularly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the different causes of antibiotic resistance?

A

CAUSES OF ANTIBIOTIC RESISTANCE

Unnecessary Prescription

Approx. 50% of antibiotic prescriptions not required

Livestock Farming

Approx. 30% of UK antibiotic use in livestock farming

Lack of Regulation

OTC availability in Russia, China, India

Lack of Development

Very few antibiotics in recent years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What percentage of bacteria have developed resistance?

A

About 70% of bacteria have developed resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the yearly death rate due to bacterial infection?

A

25,000 yearly death rate in Europe and US

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List the difference resistance mechanisms of bacteria

A

Production of Destruction Enzymes

Additional Target

Alterations in Target Enzymes

Hyperproduction

Alterations in Drug Permeation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does production of destruction enzymes lead to antibiotic resistance?

A

PRODUCTION OF DESTRUCTION ENZYMES

β-lactamases hydrolyse C-N bond of the β-lactam ring

Examples:

  • Penicillins G & V
    • gram positive
  • Flucloxacillin & Temocillin
    • β-lactamase resistant
    • not affected by this enzyme produced by many bacteria
  • Amoxicillin
    • broad spectrum
    • gram positive activity
    • co-administered with clavulanic acid
17
Q

How can an additional target lead to antibiotic resistance?

A

ADDITIONAL TARGET

Bacteria produce another target that is unaffected by the drug

Example:

  • E.coli produce different DHF reductase enzyme making them resistant to trimethoprim
18
Q

How can alterations in target enzymes lead to antibiotic resistance?

A

ALTERATIONS IN TARGET ENZYMES

Alteration to the enzyme targeted by the drug.

Enzyme still effective but drug now ineffective

Example:

  • S.Aureus - mutations in the ParC region of topoisomerase IV confers resistance to quinolones
19
Q

How can hyperproduction lead to antibiotic resistance?

A

HYPERPRODUCTION

Bacteria significantly increase levels of DHF reductase

Not the most effective method of antibiotic resistance

Example:

E. coli produce additional DHF reductase enzymes making trimethoprim less effective

20
Q

How can alterations in drug permeation lead to antibiotic resistance?

A

ALTERATIONS IN DRUG PERMEATION

Reductions in aquaporins and increased efflux systems

Less antibiotic can enter the bacteria and more antibiotic is removed from the bacteria

A common mechanism used by bacteria

Examples:

  • primarily of importance in gram negative bacteria
21
Q

How can fungal infections be classified in terms of tissue/organs?

A

SUPERFICIAL - outermost layers of skin

DERMATOPHYTE - skin, hair or nails

SUBCUTANEOUS - inntermost skin layers

SYSTEMIC - primarily respiratory tract

22
Q

How many anti-fungal drugs are licensed in the UK?

A

15 anti-fungal drugs are licensed in the UK

23
Q

What are the two most common categories of anti-fungal drugs?

A

AZOLES - Fluconazole

POLYENES - Amphotericin

24
Q

How do Azoles act as anti-fungals?

A

Inhibit cytochrome P450-dependent enzymes involved in membrane sterol synthesis

Fluconazole (oral) is used for:

  • candidasis
  • systemic infections
25
Q

How do Polyenes act as anti-fungals?

A

POLYENES

​Interact with cell membrane sterols forming membrane channels

Amphotericin (I.V.) is used for:

  • systemic infections
26
Q

A patient with a chest infection is prescribed a beta-lactam antibiotic. Which one of the following drug classes is a beta-lactam antibiotic?

A

Carbopenems

27
Q

Considering the bacterial structure and mechanism of action, which class of drug is less likely to be effective in the treatment of E.coli?

A

Glycopeptides - target production of peptidoglycan.

E.coli are gram negative and have less peptidoglycan so targeting peptidoglycan will not be effectove.

28
Q

A mutation in the ParC region of the S Aureus topoisomerase constitutes what type of resistance mechanism?

A

Enzyme alteration

29
Q

The zole drug gluconazole can be used to treat what infection?

A

Candidiasis